title: Critical review of: Efficacy of immunoglobulin plus prednisone for prevention of coronary artery prednisolone for prevention of coronary abnormalities in severe Kawasaki disease (RAISE study): a randomized, open-label, blinded-endpoints trial.
authors: Division of Emergency Medicine, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. yousef. etoom@sickkids.ca
authors: Yousef
authors: Y
authors: Etoom
authors: Rudaina
authors: R
authors: Banihani
authors: Yaron
authors: Y
authors: Finkelstein
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000517:prevention & control*; D003330:Coronary Vessel Anomalies / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D007136:Immunoglobulins; D011239:Prednisolone